Markets Denmark Stocks Health Technology Pharmaceuticals: Major

NOVO NORDISK B A/S NOVO_B

NOVO_B

OMXCOP

NOVO_B

NOVO NORDISK B A/S

OMXCOP

See more on advanced chart See more on advanced chart

No trades

Upcoming Earnings

EPS

Market Cap

Div Yield

P/E

Upcoming Earnings

EPS

Market Cap

Div Yield

P/E

See more on advanced chart See more on advanced chart

Overview

News Ideas Financials Technicals Forecast

NOVO_B chart

Ideas

A defensive stock in a rising trend

NOVO_B

, 1D

scorpiris Premium

Measured by value, Novo Nordisk is Northern Europe's largest business and headquartered in Bagsværd, Denmark. It's a defensive stock that's done well. It is considered a bit of a weakness that they have the majority of their income on few products, but on the other hand they are good at what they are doing. There are some medicine companies that have spread too...

NOVO short target 600

NOVO_B

, 1DShort

jespergarm

It seems NOVO is ending x in a corrective xyz of (4) Target 600 during april 2022 before further upside during the rest of the year

Novo Nordics about to finalize wave (3) with a wave 5

NOVO_B

, 240Long

jespergarm

Is seems NOVO is about to finish a minor wave 2 now to continue higher with an impulse to 5 There should be a long way to go still and targets between 1000 and 1400 are in reach

NOVO NORDISK potential Bearish

NOVO_B

, 1WLong

Aksel_Rom

Novo Nordisk is at a low point right now. It seems like they are getting support and could rise high very soon.

NOVO NORDISK B A/S NOVO_B week short

NOVO_B

, 1WShort

khalid1988

NOVO NORDISK B A/S NOVO_B . the week short breack out

Possible reversal coming

NOVO_B

, 1DLong

DenAlmindeligeFar

RSI hit oversold. Getting close to long term resistance at EMA200.

$NOVO #Novonordisk

NOVO_B

, 1DLong

StockTradingTips

Cylinder Accumulation by Jesse Livermore applied on Novo Nordisk.

$NOVO #Novonordisk

NOVO_B

, 1DLong

StockTradingTips

Novo Nordisk is making what looks like a Accumulation Cylinder - Jesse Livermore

$NOVO #Novonordisk

NOVO_B

, 1D

StockTradingTips

$NOVO #Novonordisk in the golden pocket. We should see some consolidation and would like to see if 700DKK hold.

NOVO NORDISK

NOVO_B

, 1WLong

StockTradingTips

BIG BEARISH DIVERGENCE IN THIS STOCK, The fall was led by SUPPLY CHAIN ISSUES on one of best selling product lines "Wegovy", but the product it self is not the challange. I BELIEVE THE FALL WAS MORE BASED ON TECHNICALS THAN FUNDAMENTALS. AS THIS STOCK RARELY SEES ANY BIG DROP LIKE IT DID, THE DRAWDOWN ON THE DAILY WAS ALMOST 17% AND CLOSED THE DAY AT -11% WHICH...

NOVO NORDISK B A/S Long short days

NOVO_B

, 1D

khalid1988

NOVONORDISK B A/S Long short days volume

NOVO_B

, 1DShort

khalid1988 Updated

NOVO_B Jeg tror på å falle i disse dager volume +vwap

NOVO_B breack Long - short Days

NOVO_B

, 1D

khalid1988 Updated

NOVO_B breack Long - short Days

NOVO_B hours long

NOVO_B

, 60Long

khalid1988

NOVO NORDISK B A/S long hours

NOVO_B

, 60Long

khalid1988

NOVO NORDISK B A/S long hours

Novo Nordisk - Decision between two channels

NOVO_B

, 1W

RJonathan Pro

Next months will show, where Novo Nordisk is heading. No position yet.

NOVO_B up hours

NOVO_B

, 1DLong

khalid1988 Updated

My analysis of Novo long hours volume + VWAP

NOVO_B days

NOVO_B

, 1D

khalid1988

NOVO_B days trend + volum+ vwap

Show more ideas

Technicals

Analyst rating

Financials

Valuation

Enterprise Value/EBITDA, TTM —

Enterprise Value, FQ —

Market Cap — Basic —

Number of Employees —

Number of Shareholders —

Price/Earnings, TTM —

Price/Revenue, TTM —

Price/Book Ratio, FY —

Price/Sales Ratio, FY —

Balance Sheet

Current Ratio, FQ —

Debt to Equity, FQ —

Net Debt, FQ —

Quick Ratio, FQ —

Total Assets, FQ —

Total Debt, FQ —

Operating Metrics

Return on Assets, TTM —

Return on Equity, TTM —

Return on Invested Capital, TTM —

Revenue per Employee, TTM —

Price History

Average Volume (10 day) —

Beta - 1 Year —

Price - 52 Week High —

Price - 52 Week Low —

Dividends

Dividends Paid, FY —

Dividends per Share, FY —

Expected Annual Dividends —

Dividends Yield —

Margins}

Net Margin, TTM —

Gross Margin, TTM —

Operating Margin, TTM —

Pretax Margin, TTM —

Income Statement

Basic EPS, Net Income —

Earnings per Share, Basic, TTM —

EBITDA, TTM —

Gross Profit, FY —

Last Annual EPS —

Last Annual Revenue, FY —

Net Income, FY —

Total Revenue, FY —

Free Cash Flow, TTM —

More financials

Profile

Sector: Health Technology

Industry: Pharmaceuticals: Major

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.